TickerLeague

Buyback Spend for Insulet (PODD)

Buyback Spend for Insulet (PODD): headline value $59.60M. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$59.60M

YoY change

N/A

5Y CAGR

N/A

Peak year (2025)

$59.60M

Latest annual

$59.60M

Buyback Spend history chart for Insulet (PODD) from 2004 to 2025

Buyback Spend history table for Insulet (PODD) from 2004 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$59.60M
2024$0
2023$0
2022$0
2021$0
2020$0
2019$0
2018$0
2017$0
2016$0
2015$0
2014$0
2013$0
2012$0
2011$0
2010$0
2009$0
2008$0
2007$0
2006$0
2005$0
2004$0

Buyback Spend values are taken from Insulet's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

Insulet (PODD) most recent annual buyback spend stands at $59.60M (2025).

The dataset's maximum buyback spend sits at $59.60M (2025); the minimum reading of $0 dates to 2004.

Within Healthcare, Insulet (PODD) ranks 8th among 8 peers we track. The peer median for buyback spend is $2.75B.

Insulet Buyback Spend by Year

Insulet Buyback Spend 2025: $59.60M

Insulet buyback spend in 2025 was $59.60M.

Insulet Buyback Spend 2024: $0

Insulet buyback spend in 2024 was $0.

Insulet Buyback Spend 2023: $0

Insulet buyback spend in 2023 was $0.

Insulet Buyback Spend 2022: $0

Insulet buyback spend in 2022 was $0.

Insulet Buyback Spend 2021: $0

Insulet buyback spend in 2021 was $0.

See more financial history for Insulet (PODD).

Sector peers — Buyback Spend

Companies in the same sector as Insulet, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AbbVie Inc. (ABBV)$980.00MHealthcare
AstraZeneca PLC (AZN)$719.66MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is Insulet's buyback spend?

Latest reported buyback spend for Insulet (PODD) is $59.60M (period ending December 31, 2025).

When did Insulet buyback spend hit its highest annual value?

Insulet buyback spend reached its highest annual value of $59.60M in 2025.

What was Insulet buyback spend in 2024?

Insulet (PODD) buyback spend in 2024 was $0.

What was Insulet buyback spend in 2025?

Insulet (PODD) buyback spend in 2025 was $59.60M.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.